Healthcare Equipment and Supplies
Company Overview of eNeura Inc.
eNeura Inc., a medical technology company, provides portable non-invasive transcranial magnetic stimulation devices for the treatment of migraine. The company offers Transcranial Magnetic Stimulation (TMS)/SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. Its SpringTMS utilizes single-pulse TMS to induce mild electrical currents that depolarize neurons in the brain. The company serves patients in the United States and the United Kingdom. eNeura Inc. was formerly known as eNeura Therapeutics LLC and changed its name to eNeura Inc. in February 2014. The company was incorporated in 2012 and is based in Baltimore, M...
801 West Baltimore Street
Suite 502 L
Baltimore, MD 21201
Founded in 2012
Key Executives for eNeura Inc.
Chief Executive Officer, President and Director
Vice President of Marketing
Compensation as of Fiscal Year 2015.
eNeura Inc. Key Developments
eNeura, Inc. Receives FDA Clearance for SpringTMS(R) Migraine Treatment Device
May 23 14
eNeura Inc. announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its SpringTMS(R) migraine treatment device. SpringTMS is the first medical device available to patients in the United States for the acute treatment of pain associated with migraine headache with aura. SpringTMS is a prescription-only device that utilizes single-pulse Transcranial Magnetic Stimulation (sTMS) to induce very mild electrical currents that can depolarize neurons in the brain. This process is thought to interrupt the abnormal hyperactivity associated with migraine. The non-invasive, proprietary device is designed for patient use. To treat, the device is placed at the back of the head where the push of a button generates a focused magnetic pulse with the intent to eliminate the pain of a migraine headache. SpringTMS provides the same therapy as the Cerena device but offers improved portability. The initial U.S. availability of SpringTMS will be launched at a select number of U.S. specialist headache centers.
eNeura Inc. Files 510(K) with FDA for SpringTMS(R) Migraine Treatment
Jan 27 14
eNeura Inc. announced that it filed a 510(k) with the U.S. Food and Drug Administration for the SpringTMS(R) transcranial magnetic stimulation (TMS) device. SpringTMS is a second-generation medical device based on company's CerenaTMS(TM), which recently received FDA clearance for the treatment of pain caused by migraine headaches preceded by an aura: a visual, sensory or motor disturbance immediately preceding the onset of a migraine attack. SpringTMS is more patient-friendly and portable compared to the previous generation device, and is already CE Marked in Europe and available by prescription in the UK. The user applies TMS to the back of the head using both hands and presses a button to generate a focused, single pulse of magnetic energy that treats the migraine headache non-invasively and without discomfort.
Similar Private Companies By Industry
Recent Private Companies Transactions
March 4, 2015
Most Searched Private Companies
Sponsored Financial Commentaries